Skip to content
★ Sign in to follow
CT

Carsten Thiel

Executive
Alexion Pharmaceuticals Inc
Total declarations
20
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (15 ops.)
€2.4M

Latest filing published 06 Mar 2017 for ALEXION PHARMACEUTICALS INC, €468k.

Filing timeline

BuySale
Carsten Thiel

Insider track record

Disclosed buys
0
Disclosed sells
15
Signal history

Carsten Thiel: trading record in brief

All filings by Carsten Thiel on record concern Alexion Pharmaceuticals Inc. In total, 20 filings cover trades dated from 27 February 2015 to 28 February 2017.

On the market, this insider has only sold: 15 sales, €2.4M in total. The amount is not disclosed for 1 filing. Besides market trades, the filings include 5 share grants. So far in 2017, the count stands at no purchases and 4 sales.

Most recently, on 6 March 2017, the filings show an open-market sale worth €468k in Alexion Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Carsten Thiel

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total
  • ▼
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    495,611 USD32SEC
    3,783 shares@ US$131.0126.1% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000067:0
  • ▼
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    9,315 USD29SEC
    71 shares@ US$131.200.5% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000056:0
  • ▼
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    0SEC
    54 shares0Common Stock, par value $.0001 per shareSEC:0000899866-17-000056:1
  • ◆
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    0SEC
    7,500 shares0Common Stock, par value $.0001 per shareSEC:0000899866-17-000056:2
  • ▼
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    20,739 USD29SEC
    165 shares@ US$125.691.1% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-17-000026:0
  • ▼
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    300,040 USD28SEC
    2,308 shares@ US$130.0015.8% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000393:0
  • ▼
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    551,364 USD26SEC
    4,584 shares@ US$120.2827.8% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000367:0
  • ▼
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    3,550 USD26SEC
    29 shares@ US$122.410.2% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000365:0
  • ▼
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    27,945 USD29SEC
    225 shares@ US$124.201.4% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000355:0
  • ▼
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    387,000 USD31SEC
    3,000 shares@ US$129.0019.2% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000355:1
  • ▼
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    125,940 USD30SEC
    1,000 shares@ US$125.946.2% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000351:0
  • ◆
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    0SEC
    5,000 shares0Common Stock, par value $.0001 per shareSEC:0000899866-16-000273:0
  • ▼
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    7,501 USD29SEC
    54 shares@ US$138.910.4% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000273:1
  • ▼
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    26,833 USD29SEC
    187 shares@ US$143.491.3% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000252:0
  • ◆
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    0SEC
    8,802 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000248:0
  • ▼
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    520,020 USD0SEC
    3,000 shares@ US$173.34Common Stock, par value $.0001 per shareSEC:0000899866-15-000197:0
  • ◆
    EVP, Chief Commercial OfficerExecutivesAlexion Pharmaceuticals Inc
    0SEC
    2,000 shares0Common Stock, par value $.0001 per shareSEC:0000899866-15-000179:0
  • ▼
    SVP, EMEA & Asia PacificExecutivesAlexion Pharmaceuticals Inc
    135,320 USD0SEC
    800 shares@ US$169.15Common Stock, par value $.0001 per shareSEC:0000899866-15-000174:0
  • ▼
    SVP, EMEA & Asia PacificExecutivesAlexion Pharmaceuticals Inc
    2,051 USD0SEC
    12 shares@ US$170.88Common Stock, par value $.0001 per shareSEC:0000899866-15-000174:1
  • ◆
    SVP, EMEA & Asia PacificExecutivesAlexion Pharmaceuticals Inc
    0SEC
    3,830 shares0Common Stock, par value $.0001 per shareSEC:0000899866-15-000073:0

20 of 20 declarations